Autotransfusion Devices Market Analysis

  • Report ID: 4459
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Autotransfusion Devices Market Analysis

Application (Orthopedic, Cardiovascular, Neurological, Gynecological, Obstetrics, Other Surgeries)

The autotransfusion devices market is segmented and analyzed for demand and supply by application into orthopedic, cardiovascular, neurological, gynecological, obstetrics, and other surgeries. Out of all, the cardiovascular surgery segment is anticipated to hold the largest market size by the end of 2037. Increased instances of cardiovascular issues are creating higher demands for transplantation, surgery, and autotransfusion, which is likely to drive the growth of the segment. According to the World Health Organization, nearly 17.9 million people are dying of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.

Product Type (Autotransfusion Systems, Accessories)

The autotransfusion devices market is segmented and analyzed for demand and supply by product type into autotransfusion systems, and accessories. Out of all, autotransfusion systems are expected to hold the highest market size by the end of 2037. Owing to their reliability in blood transfusion, autotransfusion systems are becoming more popular in both developed and emerging nations, which is predicted to propel expansion in this segment over the coming years. Furthermore, adaptability, transfusion reporting mechanisms, technological developments for enhanced clinical outcomes, and communication are predicted to propel the expansion of the dual-mode autotransfusion systems segment in the market by 2037. In November 2022, LivaNova US introduced the XtraTM autotransfusion system, which serves as a full blood management system. It combines three decades of expertise and advancements in cell salvage methods.

Our in-depth analysis of the global market includes the following segments:

             By Application

  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Neurological Surgery
  • Gynecological Surgery
  • Obstetrics
  • Other Surgeries

             By Product Type

  • Autotransfusion Systems
  • Accessories

             By End User

  • Hospitals
  •  Specialty Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4459
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of autotransfusion devices is estimated at USD 300.21 million.

The autotransfusion devices market size was valued at USD 285.15 million in 2024 and is poised to cross USD 652.68 million by the end of 2037, registering more than 6.7% CAGR during the forecast period i.e., between 2025-2037. Rise in geriatric population, growing cases of chronic disease, higher blood donation & blood transfusion and rise in surgery will impel the market growth.

Asia Pacific industry is anticipated to expand at the fastest CAGR through 2037, owing to entry of new industry players, and increasing acceptance of cell salvage technologies.

The major players in the market include ProCell Surgical Inc, .BD (Becton, Dickinson and Company), Fresenius SE & Co. KGaA, Medtronic, Beijing Jingjing Medical Equipment Co., Ltd., Haematonics Corporation, LivaNova PLC, Zimmer Biomet, SARSTEDT AG & Co. KG, Gen World Medical Devices.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample